| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/09/2009 | CN101600714A Novel kinase inhibitors |
| 12/09/2009 | CN101600707A Urea compounds useful in the treatment of cancer |
| 12/09/2009 | CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 12/09/2009 | CN101600694A Composition for treatment of undifferentiated-type of gastric cancer |
| 12/09/2009 | CN101600683A Therapeutic compounds |
| 12/09/2009 | CN101600460A Ultrasound microbubble mediated genes delivery system |
| 12/09/2009 | CN101600454A Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 12/09/2009 | CN101600445A Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 12/09/2009 | CN101597622A Series miRNA or shRNA expression vector regulated by tumour specificity promoter |
| 12/09/2009 | CN101597612A SEC2 mutant gene with increased activity of super-antigen and preparation method thereof |
| 12/09/2009 | CN101597606A SiRNA sequence aiming at protein gene like TRAP-1 and application thereof |
| 12/09/2009 | CN101597572A Oxytropis ehrig sporangium FEL6-AS2 for synthesizing SW and application thereof |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101597326A Kahalalide F and related compounds |
| 12/09/2009 | CN101597325A Method for purifying Leuprorelin |
| 12/09/2009 | CN101597324A Decapeptide inhibiting angiogenesis and use thereof |
| 12/09/2009 | CN101597321A LHRH antagonist with long-acting low-histamine release side effect |
| 12/09/2009 | CN101597317A Preparation method of chonglou saponin I and application for inhibiting angiogenesis thereof |
| 12/09/2009 | CN101597312A Vitamin A acyl cytosine arabinoside conjugate and pharmacome thereof as well as preparation methods and application thereof |
| 12/09/2009 | CN101597311A Erythromycin derivative and application thereof |
| 12/09/2009 | CN101597292A 2, 4, 6 substituent-pyridino-(3, 2-d) pyridine derivates and application thereof |
| 12/09/2009 | CN101597291A 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof |
| 12/09/2009 | CN101597290A Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof |
| 12/09/2009 | CN101597289A 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof |
| 12/09/2009 | CN101597288A 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof |
| 12/09/2009 | CN101597284A Anti-tumor compound preparation method |
| 12/09/2009 | CN101597280A Compound used as seven-pass transmembrane protein and based on sag structure |
| 12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/09/2009 | CN101597218A 3-(3-methoxyl-4-hydroxybenzyl)-4-aromatic-hexene (hexane) and medicinal application thereof |
| 12/09/2009 | CN101597212A Kirenol derivative and application thereof in preparation of proinflammatory cytokine inhibitor |
| 12/09/2009 | CN101596320A Medicament for treating tumor and application thereof |
| 12/09/2009 | CN101596316A Recombinant adenovirus expressing FoxMlsiRNA and application of tumor therapy and prevention thereof |
| 12/09/2009 | CN101596315A Application of ZNF300 immune body of people for preparing medicines for treating and preventing leukemia |
| 12/09/2009 | CN101596307A Application of recombinant FN heparin binding domain polypeptide on preparing medicament resisting invasion and metastasis of malignant tumor |
| 12/09/2009 | CN101596306A Pharmaceutical formulations for sustained drug delivery |
| 12/09/2009 | CN101596301A Method for preparing medicament for preventing and curing tumour |
| 12/09/2009 | CN101596293A Beverage for life extension and survival |
| 12/09/2009 | CN101596267A Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof |
| 12/09/2009 | CN101596255A Chinese medicament for preventing and curing leucemia |
| 12/09/2009 | CN101596237A Traditional Chinese medicine preparation for treating chronic granulocytic leukemia |
| 12/09/2009 | CN101596227A Chinese herbal medicinal preparation for treating advanced lung cancer |
| 12/09/2009 | CN101596225A Anti-tumour traditional Chinese medicine preparation containing glossy ganoderma spore oil and preparation method thereof |
| 12/09/2009 | CN101596202A Application of tanshinone IIA emulsion on treating liver diseases |
| 12/09/2009 | CN101596196A Ligustrazine and danshensu composition and pharmacology activity research |
| 12/09/2009 | CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 12/09/2009 | CN101596187A Anti-cancer combinations |
| 12/09/2009 | CN101596186A Anti-cancer combinations |
| 12/09/2009 | CN101596159A New taxol injection and preparation method thereof |
| 12/09/2009 | CN101596155A Teniposide solid lipid nanoparticle and preparation method thereof |
| 12/09/2009 | CN101595982A Natural anticancer medical rice gruel and preparation method thereof |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567323C Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 12/09/2009 | CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same |
| 12/09/2009 | CN100567318C Nucleoside active matter in Artificially cultivating cordycepin and its preparing method and use |
| 12/09/2009 | CN100567301C Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 12/09/2009 | CN100567291C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 12/09/2009 | CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives |
| 12/09/2009 | CN100567285C Joglone possessing anti cancer activity and its preparation method |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100567242C Hsp90 family protein inhibitors |
| 12/09/2009 | CN100566750C An auto T cell vaccine against T lymphocytoma and preparation method thereof |
| 12/09/2009 | CN100566743C Chinese herb for inhibiting tumor and its preparation |
| 12/09/2009 | CN100566712C Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/09/2009 | CN100566711C Compound for the treatment of cancer and use thereof |
| 12/09/2009 | CN100566599C Method for preparing sweet potato meal fiber tablets |
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament |
| 12/08/2009 | US7629439 Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy |
| 12/08/2009 | US7629438 Microbiocide for use in treatment and prevention of infection; antitumor agents |
| 12/08/2009 | US7629383 Double esters |
| 12/08/2009 | US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/08/2009 | US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/08/2009 | US7629364 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629352 Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629347 Modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; cancer; chronic myelogic leukemia |
| 12/08/2009 | US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/08/2009 | US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7629132 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, apoptosis and autoimmune diseases |
| 12/08/2009 | US7629003 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 12/08/2009 | US7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 12/08/2009 | US7628989 Methods of inducing an immune response |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | CA2434829C New benzoylguanidine salt |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2419301C Quinazoline derivatives |
| 12/08/2009 | CA2415486C Pyramidine derivatives |
| 12/08/2009 | CA2404725C Extrusion die |
| 12/08/2009 | CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/08/2009 | CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |